We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
1
Vanguard S&P 500 ETF
VOO
$968B
$6.81B 6.89%
20,746,045
+634,224
+3% +$232M
AGG icon
2
iShares Core US Aggregate Bond ETF
AGG
$138B
$4.48B 4.53%
46,527,580
+6,127,129
+15% +$620M
AAPL icon
3
Apple
AAPL
$4.89T
$2.65B 2.68%
19,162,457
+1,138
+0% +$179K
MSFT icon
4
Microsoft
MSFT
$2.84T
$2.48B 2.5%
10,627,050
+110,494
+1% +$29.2M
USMV icon
5
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
$2.1B 2.12%
31,722,146
+3,852
+0% +$278K
IEFA icon
6
iShares Core MSCI EAFE ETF
IEFA
$186B
$1.43B 1.44%
27,081,225
+699,309
+3% +$41.1M
AMZN icon
7
Amazon
AMZN
$2.5T
$1.31B 1.32%
11,558,372
+103,525
+0.9% +$13.1M
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$924M 0.93%
2,585,997
+19,037
+0.7% +$7.56M
HD icon
9
Home Depot
HD
$332B
$922M 0.93%
3,341,229
+16,102
+0.5% +$4.75M
UNH icon
10
UnitedHealth
UNH
$382B
$913M 0.92%
1,808,169
-6,785
-0.4% -$3.57M
JNJ icon
11
Johnson & Johnson
JNJ
$634B
$893M 0.9%
5,467,856
+107,613
+2% +$18.2M
JPM icon
12
JPMorgan Chase
JPM
$939B
$829M 0.84%
7,930,380
+358,488
+5% +$41.1M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$3.91T
$792M 0.8%
8,284,714
+110,294
+1% +$12.2M
MRK icon
14
Merck
MRK
$324B
$778M 0.79%
9,034,460
+272,275
+3% +$24.3M
AVGO icon
15
Broadcom
AVGO
$1.82T
$682M 0.69%
15,362,230
-136,340
-0.9% -$6.97M
VTEB icon
16
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$669M 0.68%
13,893,847
+2,746,182
+25% +$137M
IJR icon
17
iShares Core S&P Small-Cap ETF
IJR
$109B
$643M 0.65%
7,380,024
+273,419
+4% +$26.6M
UNP icon
18
Union Pacific
UNP
$182B
$641M 0.65%
3,288,651
+104,219
+3% +$23.1M
V icon
19
Visa
V
$677B
$635M 0.64%
3,574,762
-10,954
-0.3% -$2.23M
IWF icon
20
iShares Russell 1000 Growth ETF
IWF
$122B
$632M 0.64%
12,010,060
+1,126,948
+10% +$66.3M
VO icon
21
Vanguard Mid-Cap ETF
VO
$106B
$615M 0.62%
13,078,608
+440,868
+3% +$23M
VZ icon
22
Verizon
VZ
$194B
$601M 0.61%
15,839,951
-175,184
-1% -$7.8M
XLV icon
23
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$581M 0.59%
4,796,104
+275,367
+6% +$35.5M
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.07T
$579M 0.59%
2,168,155
+46,375
+2% +$13.2M
IJH icon
25
iShares Core S&P Mid-Cap ETF
IJH
$123B
$548M 0.55%
12,501,545
+327,265
+3% +$15.8M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.